Literature DB >> 39570

Pharmacological properties of 6-(o-chlorophenyl)-8-ethyl-1-methyl-4H-s-triazolo[3,4-c]thieno[2,3-e] [1,4]diazepine (Y-7131), a new anti-anxiety drug.

T Tsumagari, A Nakajima, T Fukuda, S Shuto, T Kenjo, Y Morimoto, Y Takigawa.   

Abstract

6-(o-Chlorophenyl)-8-ethyl-1-methyl-4H-s-triazolo[3,4-c]thienol[2,3-e][1,4]diazepine (Y-7131), a new derivative of the thienodiazepines, had marked activities in antipentylenetetrazole effect in mice, attenuation of conflict behavior in rats, inhibition of aggressive behavior induced by hypothalamic stimulation in cats and muscle relaxant effects in normal and decerebrate cats. Y-7131 had weak activities in anti-MES effect in mice and loss of righting reflex in mice. The acute toxicity of Y-7131 was considerably lower than that of diazepam. No significant autonomic or neuroleptic effects were noted. Y-7131 appears to be a characteristic and potent anti-anxiety agent different from the benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 39570

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  7 in total

1.  Induction of the metabolism of etizolam by carbamazepine in humans.

Authors:  S Kondo; T Fukasawa; N Yasui-Furukori; T Aoshima; A Suzuki; Y Inoue; T Tateishi; K Otani
Journal:  Eur J Clin Pharmacol       Date:  2005-03-18       Impact factor: 2.953

2.  Single and multiple dose pharmacokinetics of etizolam in healthy subjects.

Authors:  C Fracasso; S Confalonieri; S Garattini; S Caccia
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Effects of several benzodiazepines, alone and in combination with flumazenil, in rhesus monkeys trained to discriminate pentobarbital from saline.

Authors:  W L Woolverton; M A Nader
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

4.  Pharmacokinetics and pharmacodynamics of etizolam are influenced by polymorphic CYP2C19 activity.

Authors:  T Fukasawa; N Yasui-Furukori; A Suzuki; Y Inoue; T Tateishi; K Otani
Journal:  Eur J Clin Pharmacol       Date:  2005-11-01       Impact factor: 2.953

5.  Effects of etizolam and ethyl loflazepate on the P300 event-related potential in healthy subjects.

Authors:  Goro Fukami; Tasuku Hashimoto; Yukihiko Shirayama; Tadashi Hasegawa; Hiroyuki Watanabe; Mihisa Fujisaki; Kenji Hashimoto; Masaomi Iyo
Journal:  Ann Gen Psychiatry       Date:  2010-11-03       Impact factor: 3.455

6.  Inhibition of the metabolism of etizolam by itraconazole in humans: evidence for the involvement of CYP3A4 in etizolam metabolism.

Authors:  K Araki; N Yasui-Furukori; T Fukasawa; T Aoshima; A Suzuki; Y Inoue; T Tateishi; K Otani
Journal:  Eur J Clin Pharmacol       Date:  2004-07-01       Impact factor: 2.953

7.  The pharmacological properties of Y-23684, a benzodiazepine receptor partial agonist.

Authors:  H Yasumatsu; Y Morimoto; Y Yamamoto; S Takehara; T Fukuda; T Nakao; M Setoguchi
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.